- Home
- PBYI vs POWW Comparison
PBYI vs POWW Comparison
Compare PBYI & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | POWW |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 210.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PBYI | POWW |
|---|---|---|
| Price | $7.04 | $1.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $7.00 | $2.38 |
| AVG Volume (30 Days) | ★ 411.3K | 391.6K |
| Earning Date | 02-26-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.87 | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $211,995,000.00 | $46,632,638.00 |
| Revenue This Year | N/A | $9.85 |
| Revenue Next Year | N/A | $1.88 |
| P/E Ratio | $9.16 | ★ N/A |
| Revenue Growth | N/A | ★ 1343.57 |
| 52 Week Low | $2.58 | $1.08 |
| 52 Week High | $7.21 | $2.14 |
Technical Indicators
Market Signals| Indicator | PBYI | POWW |
|---|---|---|
| Relative Strength Index (RSI) | 68.59 | 42.16 |
| Support Level | $6.27 | $1.60 |
| Resistance Level | $6.64 | $1.75 |
| Average True Range (ATR) | 0.32 | 0.07 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 89.15 | 20.59 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.